PharmacoEconomics & Outcomes News

, Volume 799, Issue 1, pp 27–27 | Cite as

Nivolumab cost effective for advanced melanoma in England

Clinical study


  1. Meng Y, et al. The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England. European Journal of Health Economics : 9 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations